Effect of the 5-HT(1A) partial agonist buspirone on regional brain electrical activity in man: A functional neuroimaging study using low-resolution electromagnetic tomography (LORETA)

Psychiatry Research - Neuroimaging

Volumn 100, Issue 2, 2000, Pages 81-96

  Anderer, Peter ^a   Saletu, Bernd ^a   Pascual Marqui, Roberto D ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

Pharmaco EEG; Psychopharmacology; Quantitative electroencephalography

Indexed keywords

ALNESPIRONE; BUSPIRONE; PLACEBO; SEROTONIN 1A AGONIST;

ADULT; ALPHA RHYTHM; ARTICLE; BETA RHYTHM; BRAIN TOMOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHARMACODYNAMICS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THETA RHYTHM;

ADULT; BRAIN; BUSPIRONE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROENCEPHALOGRAPHY; ELECTROMAGNETICS; FEMALE; HUMANS; MALE; SEROTONIN AGONISTS;

EID: 0034606176     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(00)00066-4     Document Type: Article

References (88)

1. Topographic brain mapping of EEG in neuropsychopharmacology - Part I. Methodological aspects
2. Artifact processing in topographic mapping of electroencephalopraphic activity in neuropsychopharmacology
3. Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA)
4. Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography. 1. Effects of normal aging
5. Electrical sources of P300 event-related brain potentials revealed by low resolution electromagnetic tomography. 2. Effects of nootropic therapy in age-associated memory impairment
6. Buspirone: future directions
7. Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence
8. Reversed hemispheric asymmetry of imipramine binding in suicide victims
9. Location of sources of evoked scalp potentials: corrections for skull and scalp thickness
10. Topographic pharmaco-EEG mapping of increasing doses of buspirone and its comparison with diazepam
11. Serotonin and panic
12. A double-blind comparison of buspirone, clobazam and placebo in patients with anxiety treated in general practice setting
13. Neuroelectric mapping reveals precursor of stop failures in children with attention deficits
14. A functional anatomy of anticipatory anxiety
15. Pooled, double-blind comparison of the effect of buspirone, diazepam, and placebo in women with chronic anxiety
16. Serotonin receptor subtypes: implication for psychopharmacology
17. Use of the binomial theorem in interpreting results of multiple tests of significance
18. 3H-imipramine binding may predict psychiatric illness
19. Pharmacological challenge and PET imaging
20. Azaspirones: clinical uses of serotonin partial agonist
21. Cerebral blood flow during anxiety provocation
22. Comparing functional (PET) images: the assessment of significant change
23. The neurotransmitter basis of cognition: psychopharmacological activation studies using positron emission tomography
24. Statistical parametric mapping and other analyses of functional imaging data
25. Mood state and brain electrical activity in ecstasy users
26. Concentration of buspirone and 1-pyrimidinylpiperazine, a metabolite in rat brain
27. 2-adrenoceptors in the rat brain
28. Effect of the 5-HT(1A) partial agonist buspirone on regional cerebral blood flow in man
29. A critical analysis of linear inverse solutions
30. Linear inverse solutions with optimal resolution kernels applied to the electromagnetic tomography
31. The effect of biologically-active light on the noo- and thymopsyche and on psychophysiological variables in healthy volunteers
32. Single dose human pharmacology of umespirone
33. Serotonergic function in obsessive-compulsive disorder. Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers
34. Psychophysiological effects of self-regulation method: EEG frequency analysis and contingent negative variation
35. Spectral analysis of the central nervous system effects of the relaxation response elicited by autogenic training
36. EEG power spectrum changes due to listening to pleasant music and their relation to relaxation effects
37. Serotonin and anxiety revisited
38. Relaxation-induced EEG alterations in panic disorder patients
39. Trends in EEG source localization
40. EEG source localization: implementing the spatio-temporal decomposition approach
41. Reflections on the topics: EEG frequency bands and regulation of vigilance
42. Imaging of serotonin and dopamine transporters in the living human brain
43. Automated labeling of the human brain - a preliminary report on the development and evaluation of a forward transform method
44. Extracranial localization of intracranial interictal epileptiform activity using LORETA (low resolution electromagnetic tomography)
45. Psychometrische und psychophysiologische Studien mit 3 Einzeldosierungen von S-20499, einem neuen selektiven 5HT(1A)-Rezeptor Agonisten
46. Positron emission tomographic imaging of serotonin activation effects on prefrontal cortex in healthy volunteers
47. The neurobiology of suicide risk: a review for the clinician
48. Dopamine receptor antagonism by the novel antianxiety drug, buspirone
49. Spatiotemporal EEG anaylsis and distributed source estimation in presurgical epilepsy evaluation
50. Phase I study of a new antianxiety drug, buspirone
51. Anxiety, emotion and cerebral blood flow
52. Low resolution electromagnetic tomography
53. Review of methods for solving the EEG inverse problem
54. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain
55. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia
56. Serotonin 5-HT1A agonists: a comprehensive review
57. Evaluation of buspirone as antianxiety agent: buspirone and diazepam versus placebo
58. Face-elicited ERPs and affective attitude: brain electric microstate and tomography analysis
59. Buspirone and diazepam in anxiety: a controlled study
60. Mood disorders following stroke: new findings and future directions
61. Quantitative pharmaco-EEG study of ipsapirone (BAY q 7821) in healthy volunteers
62. On differences between 1,5- and 1,4-benzodiazepines: pharmaco-EEG and psychometric studies with clobazam and lorazepam
63. Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: electroencephalographic brain mapping and safety evaluation
64. Clinical-pharmacological study with the two isomers (D-,L-) of fenfluramine and its comparison with chlorpromazine and D-amphetamine: blood levels, EEG mapping and safety evaluation
65. Pharmacodynamics and EEG. II. From EEG-mapping to EEG-tomography
66. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnographic and EEG mapping
67. Neurobiologic basis of anxiety and its treatment
68. Buspirone, a non-bezodiazepine anxiolytic, increases locus coeruleus noradrenergic neuronal activity
69. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP
70. Kapalabhati-yogic cleansing exercise. II. EEG topography anaylsis
71. Three-dimensional tomography of event-related potentials during response inhibition: evidence for phasic frontal lobe activation
72. The spatial location of EEG electrodes: locating the best-fitting sphere relative to cortical anatomy
73. The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia
74. The continuous performance test revisited with neuroelectric mapping: impaired orienting in children with attention deficits
75. Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression)
76. Die Befindlichkeitsskala (B-S) - ein einfaches Instrument zur Objektivierung von Befindlichkeitsstorungen, insbesondere im Rahmen von Langsschnittuntersuchungen
77. Attention-sensitive visual event-related potentials elicited by kinetic forms
78. Buspirone: multicenter efficacy study
79. The interaction of serotonin depletion with anxiolytics and antidepressants on reticular-elicited hippocampal RSA